For example, in numerous studies concerning programmed death-ligand 1 (PD-L1), multiplexed imaging technologies seemed to improve performance in predicting response to anti-PD-L1/programmed cell death protein 1 (PD-1) treatment of different solid tumors, as well as tumor mutational burden and gene expression profiling (11–13). This evidence concerns the gene CD274 and neoplasm.